A phase 3 Study of ensitrelvir in japanese participants aged 6-11 years with SARS-CoV-2 infection.

A phase 3 Study of ensitrelvir in japanese participants aged 6-11 years with SARS-CoV-2 infection.

Publication date: Aug 19, 2026

Children aged

Concepts Keywords
Covid Ensitrelvir
Infection Japan
Japanese Pediatric COVID-19
Pediatric Pharmacokinetics
Years

Semantics

Type Source Name
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH Long Covid

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *